Lupin Ltd

PartnershipAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Lupin Partnership

Lupin Limited's subsidiary VISUfarma B.V. signed an exclusive license agreement with Visus Therapeutics to commercialize YUVEZZI™ in Europe. The deal includes potential consideration of €75 million.

Value

₹832.5 Cr

Execution

Initial term until 20th anniversary of first commercial sale

Partnership

Lupin Partnership

Lupin collaborated with Laboratorios ERN S.A. to launch its Luforbec inhaler in Spain. This strategic partnership expands Lupin's respiratory market footprint into the Spanish therapeutic sector.